Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Costs, quality of life, treatment satisfaction and compliance in patients with beta-thalassemia major undergoing iron chelation therapy: the ITHACA study.

Scalone L, Mantovani LG, Krol M, Rofail D, Ravera S, Bisconte MG, Borgna-Pignatti C, Borsellino Z, Cianciulli P, Gallisai D, Prossomariti L, Stefàno I, Cappellini MD.

Curr Med Res Opin. 2008 Jul;24(7):1905-17. doi: 10.1185/03007990802160834 . Epub 2008 May 27.

PMID:
18507891
2.

Survival and complications in thalassemia.

Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, Ghilardi R, Origa R, Piga A, Romeo MA, Zhao H, Cnaan A.

Ann N Y Acad Sci. 2005;1054:40-7. Review.

PMID:
16339650
3.

Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder.

Bereza BG, Machado M, Einarson TR.

Clin Ther. 2009 Jun;31(6):1279-308. doi: 10.1016/j.clinthera.2009.06.004. Review.

PMID:
19695395
4.

Quality of life assessment in clinical practice in haemophilia treatment.

Gringeri A, Mantovani L, Mackensen SV.

Haemophilia. 2006 Jul;12 Suppl 3:22-9. Review.

PMID:
16683993
5.
6.

A thalassemic child becomes adult.

Galanello R.

Rev Clin Exp Hematol. 2003 Mar;7(1):4-21. Review.

PMID:
14692232
7.

Pharmacoeconomic considerations in treating iron overload in patients with β-thalassaemia, sickle cell disease and myelodysplastic syndromes in the US: a literature review.

Zhang B, Donga PZ, Corral M, Sasane M, Miller JD, Pashos CL.

Pharmacoeconomics. 2011 Jun;29(6):461-74. doi: 10.2165/11589250-000000000-00000. Review.

PMID:
21452907
8.

Current status in iron chelation in hemoglobinopathies.

Cappellini MD, Piga A.

Curr Mol Med. 2008 Nov;8(7):663-74. Review.

PMID:
18991652
9.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

10.

Treatment of iron overload in thalassemia.

Cianciulli P.

Pediatr Endocrinol Rev. 2008 Oct;6 Suppl 1:208-13. Review.

PMID:
19337180
11.

The impact of iron overload and its treatment on quality of life: results from a literature review.

Abetz L, Baladi JF, Jones P, Rofail D.

Health Qual Life Outcomes. 2006 Sep 28;4:73. Review.

12.

Thalassemia and learning: Neurocognitive functioning in children.

Armstrong FD.

Ann N Y Acad Sci. 2005;1054:283-9. Review.

PMID:
16339676
13.

Thalassemia intermedia: revisited.

Taher A, Isma'eel H, Cappellini MD.

Blood Cells Mol Dis. 2006 Jul-Aug;37(1):12-20. Epub 2006 Jun 5. Review.

PMID:
16737833
14.

Beta-thalassemia: the Lebanese experience.

Inati A, Zeineh N, Isma'eel H, Koussa S, Gharzuddine W, Taher A.

Clin Lab Haematol. 2006 Aug;28(4):217-27. Review.

PMID:
16898958
15.

Cross-talk between available guidelines for the management of patients with beta-thalassemia major.

Musallam KM, Angastiniotis M, Eleftheriou A, Porter JB.

Acta Haematol. 2013;130(2):64-73. doi: 10.1159/000345734. Epub 2013 Mar 13. Review.

16.

Endocrine complications in patients with Thalassaemia Major.

Toumba M, Sergis A, Kanaris C, Skordis N.

Pediatr Endocrinol Rev. 2007 Dec;5(2):642-8. Review.

PMID:
18084158
17.

Congestive heart failure and treatment in thalassemia major.

Aessopos A, Kati M, Tsironi M.

Hemoglobin. 2008;32(1-2):63-73. doi: 10.1080/03630260701680839. Review.

PMID:
18274984
18.

For goodness' sake: expected therapeutic benefit as a basis for healthcare delivery.

Denton TA, Diamond GA.

Clin Chem. 1995 May;41(5):799-804. Review.

19.

Quality of life in thalassemia.

Telfer P, Constantinidou G, Andreou P, Christou S, Modell B, Angastiniotis M.

Ann N Y Acad Sci. 2005;1054:273-82. Review.

PMID:
16339675
20.

The management of patients with Cooley's anemia: transfusions and splenectomy.

Piomelli S.

Semin Hematol. 1995 Oct;32(4):262-8. Review. No abstract available.

PMID:
8560283

Supplemental Content

Support Center